ALAN W. HELDMAN, M.D.
Osteopathic Medicine at 14 St, Miami, FL

License number

Florida D44970

Personal information

See more information about ALAN W. HELDMAN at radaris.com

Name

Address

Phone

Alan Heldman

11406 Four Fillies Rd, Miami, FL 33156

Alan Heldman

4450 Nautilus Dr, Miami Beach, FL 33140

Organization information

See more information about ALAN W. HELDMAN at bizstanding.com

Alan W Heldman MD

1120 NW 14 St #1105, Miami, FL 33136

Categories:

Cardiology Physicians & Surgeons

Phone:

(305) 243-5138 (Phone)

Professional information

Professor Of Medicine, Interventional Cardiologist, Vice-Chief Of The Cardiovascular Division, University Of Miami

Position:

Cardiovascular Chief at University of Miami, Director of Translational Research, Stem Cell Institute at University of Miami

Location:

Miami/Fort Lauderdale Area

Industry:

Medical Practice

Work:

University of Miami since Mar 2007 - Cardiovascular Chief University of Miami since Mar 2007 - Director of Translational Research, Stem Cell Institute American Heart Association 2007 - 2009 - Chair, Go Red for Women Johns Hopkins School of Medicine 2000 - 2007 - Director of Interventional Cardiology Research Johns Hopkins University School of Medicine 1995 - 2007 - Physician; Interventional Cardiologist Johns Hopkins Hospital 1995 - 2007 - Interventional Cardiologist

Education:

The Johns Hopkins University School of Medicine 1988 - 1995
University of Alabama School of Medicine 1984 - 1988
MD with honors, Medicine Harvard University 1980 - 1984
AB cum laude, History of Science

Skills:

Medical Devices, Interventional Cardiology, Cell Therapy, Hospitals, Medicine, Clinical Trials, Internal Medicine, Cardiovascular Disease, Stem Cells, Therapists, Cardiology, Clinical Research, Medical Education, Medical Imaging, Surgery, Healthcare, Healthcare Management, EHR, Vascular, Medical Research, Clinical Development, Translational Research, Heart Failure

Interests:

Complex and high-risk coronary intervention, Hypertrophic cardiomyopathy, including treatment with alcohol septal ablation, Percutaneous treatment of structural heart disease, percutaneous valve replacement, Techniques to reduce or eliminate complications from interventional procedures, Restenosis, Stem cells, Stem cell therapy for myocardial infarction and heart failure

Honor & Awards:

FSCAI (Fellow of the Society for Cardiovascular Angiography and Interventions)

Dr. Alan W Heldman, Miami FL - MD (Doctor of Medicine)

Address:

University of Miami Cardiovascular Division
1295 NW 14Th St SUITE A, Miami 33125
(305) 243-5554 (Phone)

Hospitals:

University of Miami Cardiovascular Division
1295 NW 14Th St SUITE A, Miami 33125
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136

Education:

Medical Schools
University Of Alabama School Of Medicine
Graduated: 1988

Alan Wohl Heldman, Miami FL

Specialties:

Cardiologist

Address:

1295 Nw 14Th St, Miami, FL 33125
1120 Nw 14Th St, Miami, FL 33136
1500 Nw 12Th Ave, Miami, FL 33136

Education:

University of Alabama, School of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Interventional Cardiology (Internal Medicine)
Johns Hopkins Hospital - Residency - Internal Medicine

Board certifications:

American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)

Reverse Tapered Guidewire And Method Of Use

US Patent:

2008005, Mar 6, 2008

Filed:

Feb 6, 2007

Appl. No.:

11/702915

Inventors:

Anthony Nobles - Fountain Valley CA, US
Alan Heldman - Miami Beach FL, US

International Classification:

A61B 17/04

US Classification:

606148000, 128898000

Abstract:

A reverse tapered guidewire may comprise a proximal segment and a distal segment. The proximal segment may have a cross-sectional diameter smaller than a cross-sectional diameter of the distal segment. The guidewire may be inserted through an access site on a patient. A medical device may be advanced over the proximal segment of the guidewire. After the medical device is withdrawn from the patient, the guidewire may be used to re-access the site.